Back

Twelve months results from a prospective real-world multicenter clinical practice of CAS using the CGuard Embolic Prevention System (EPS): The IRONGUARD 2 study

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: New Insights into cardiovascular surgery Carotid and Peripheral Arteries ESC Premium Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Pasqualino Sirignano

Sapienza University of Rome, Rome (Italy)

3 More presentations in this session

Presentation thumbnail
Higher levels of serum phosphorus are associated with coronary calcification post heart transplantation
Doctor I. Ozcan (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Sarcomere ACTC1 and MYO18A serum expression levels detect acute cellular rejection in cardiac transplant patients
Miss L. Perez Carrillo (Valencia, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of staging right heart failure in patients with significant tricuspid regurgitation undergoing tricuspid valve surgery
Doctor X. Galloo (Brussels, BE)
Abstract Slides Video

Access the full session

Session thumbnail
New Insights into cardiovascular surgery

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Congress Session
2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases: Ask the Guidelines Task Force
thumbnail
Congress Session
2024 ESC Guidelines for the Management of Peripheral Arterial and Aortic Diseases
thumbnail
Congress Session
Meet the Experts: peripheral artery disease from diagnosis to interventions

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources